Angiodynamics (ANGO) Operating Income (2016 - 2025)
Historic Operating Income for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$6.1 million.
- Angiodynamics' Operating Income rose 4479.0% to -$6.1 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$32.5 million, marking a year-over-year increase of 8635.73%. This contributed to the annual value of -$40.0 million for FY2025, which is 7923.77% up from last year.
- Latest data reveals that Angiodynamics reported Operating Income of -$6.1 million as of Q4 2025, which was up 4479.0% from -$10.7 million recorded in Q3 2025.
- Angiodynamics' 5-year Operating Income high stood at $35.0 million for Q3 2023, and its period low was -$199.9 million during Q1 2024.
- Over the past 5 years, Angiodynamics' median Operating Income value was -$9.5 million (recorded in 2023), while the average stood at -$17.7 million.
- Per our database at Business Quant, Angiodynamics' Operating Income skyrocketed by 36336.37% in 2023 and then crashed by 213897.85% in 2024.
- Over the past 5 years, Angiodynamics' Operating Income (Quarter) stood at -$8.7 million in 2021, then grew by 6.5% to -$8.1 million in 2022, then crashed by 61.68% to -$13.1 million in 2023, then rose by 15.44% to -$11.1 million in 2024, then soared by 44.79% to -$6.1 million in 2025.
- Its Operating Income was -$6.1 million in Q4 2025, compared to -$10.7 million in Q3 2025 and -$5.8 million in Q2 2025.